NVO logo

Novo Nordisk A/S (NVO) Operating Profit

Annual Operating Profit

$18.62 B
+$3.73 B+25.03%

December 31, 2024

Summary

Performance

1-Year Change

+25.03%

3-Year Change

+99.55%

5-Year Change

+136.62%

15-Year Change

+149.82%

NVO Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.76%
NVO annual operating income is higher than 99.76% of companies in Healthcare sector

High & Low

All-time High

$18.62 B
NVO annual operating income is currently at an all-time high

3-Year Low

$9.33 B
NVO annual operating income is currently +99.55% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

Annual Operating Margin

44.19%
NVO annual operating profit margin is 44.19%

Annual Revenue

$42.13 B
NVO annual revenue is $42.13 billion

Annual Net Income

$14.65 B
NVO annual net profit is $14.65 billion

Annual EPS

$3.28
NVO annual earnings per share is $3.28

Quarterly Operating Profit

$5.25 B
+$264.84 M+5.31%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+40.23%

3-Year Change

+150.31%

5-Year Change

+198.23%

NVO Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.92%
NVO quarterly operating income is higher than 99.92% of companies in Healthcare sector

High & Low

All-time High

$5.25 B
NVO quarterly operating income is currently at an all-time high

3-Year Low

$2.10 B
NVO quarterly operating income is currently +150.31% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

Quarterly Operating Margin

42.88%
NVO quarterly operating profit margin is 42.88%

Quarterly Revenue

$12.24 B
NVO quarterly revenue is $12.24 billion

Quarterly Net Income

$4.03 B
NVO quarterly net profit is $4.03 billion

Quarterly EPS

$0.91
NVO quarterly earnings per share is $0.91

TTM Operating Profit

$18.62 B
+$1.39 B+8.05%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+15.09%

3-Year Change

+99.34%

5-Year Change

+136.37%

NVO TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.75%
NVO TTM operating income is higher than 99.75% of companies in Healthcare sector

High & Low

All-time High

$18.62 B
NVO TTM operating income is currently at an all-time high

3-Year Low

$9.34 B
NVO TTM operating income is currently +99.34% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

Annual Operating Margin

44.19%
NVO annual operating profit margin is 44.19%

TTM Revenue

$42.09 B
NVO TTM revenue is $42.09 billion

TTM Net Income

$14.65 B
NVO TTM net profit is $14.65 billion

TTM EPS

$3.28
NVO TTM earnings per share is $3.28

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

$18.62 B
NVO annual operating income is $18.62 billion

Annual Gross Profit

$35.67 B
NVO annual gross profit is $35.67 billion

Annual Operating Expenses

$17.05 B
NVO annual total operating expenses is $17.05 billion

NVO Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.0%+40.2%+15.1%
3 y3 years+99.5%+150.3%+99.3%
5 y5 years+136.6%+198.2%+136.4%

NVO Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+99.5%at high+150.3%at high+99.3%
5 y5-yearat high+136.6%at high+198.2%at high+136.4%
alltimeall timeat high>+9999.0%at high+386.1%at high+2602.8%

Novo Nordisk A/S Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
$18.62 B(+25.0%)
$5.25 B(+5.3%)
$18.62 B(+8.0%)
Sep 2024
-
$4.98 B(+33.2%)
$17.23 B(+6.5%)
Jun 2024
-
$3.74 B(-19.3%)
$16.18 B(+1.6%)
Mar 2024
-
$4.64 B(+20.1%)
$15.92 B(+6.9%)
Dec 2023
$14.89 B(+40.4%)
$3.86 B(-1.7%)
$14.89 B(+11.3%)
Sep 2023
-
$3.93 B(+12.6%)
$13.38 B(+9.8%)
Jun 2023
-
$3.49 B(-3.2%)
$12.18 B(+7.6%)
Mar 2023
-
$3.61 B(+53.5%)
$11.32 B(+6.8%)
Dec 2022
$10.60 B(+13.6%)
$2.35 B(-14.0%)
$10.60 B(+2.4%)
Sep 2022
-
$2.73 B(+3.8%)
$10.35 B(+3.1%)
Jun 2022
-
$2.63 B(-8.8%)
$10.04 B(+2.4%)
Mar 2022
-
$2.89 B(+37.7%)
$9.80 B(+4.9%)
Dec 2021
$9.33 B(+12.5%)
$2.10 B(-13.3%)
$9.34 B(+3.4%)
Sep 2021
-
$2.42 B(+0.9%)
$9.03 B(+4.7%)
Jun 2021
-
$2.40 B(-1.4%)
$8.63 B(+4.2%)
Mar 2021
-
$2.43 B(+35.6%)
$8.27 B(+0.3%)
Dec 2020
$8.29 B(+5.4%)
$1.79 B(-11.0%)
$8.25 B(+0.4%)
Sep 2020
-
$2.01 B(-1.5%)
$8.22 B(+1.1%)
Jun 2020
-
$2.04 B(-15.1%)
$8.13 B(+0.2%)
Mar 2020
-
$2.41 B(+36.7%)
$8.12 B(+3.0%)
Dec 2019
$7.87 B(+5.1%)
$1.76 B(-8.5%)
$7.88 B(+1.4%)
Sep 2019
-
$1.92 B(-4.9%)
$7.76 B(+1.1%)
Jun 2019
-
$2.02 B(-6.6%)
$7.68 B(+0.9%)
Mar 2019
-
$2.17 B(+31.5%)
$7.61 B(+1.5%)
Dec 2018
$7.48 B(+0.4%)
$1.65 B(-10.5%)
$7.50 B(+0.8%)
Sep 2018
-
$1.84 B(-5.8%)
$7.44 B(-0.8%)
Jun 2018
-
$1.96 B(-4.8%)
$7.50 B(-0.3%)
Mar 2018
-
$2.05 B(+29.2%)
$7.53 B(+1.6%)
Dec 2017
$7.45 B(+3.5%)
$1.59 B(-16.5%)
$7.40 B(-0.5%)
Sep 2017
-
$1.90 B(-3.8%)
$7.44 B(+0.6%)
Jun 2017
-
$1.98 B(+2.4%)
$7.40 B(+1.1%)
Mar 2017
-
$1.93 B(+18.9%)
$7.32 B(+1.6%)
Dec 2016
$7.20 B(-2.1%)
$1.62 B(-12.8%)
$7.20 B(-0.1%)
Sep 2016
-
$1.86 B(-1.8%)
$7.21 B(+1.1%)
Jun 2016
-
$1.90 B(+4.2%)
$7.13 B(+0.7%)
Mar 2016
-
$1.82 B(+11.6%)
$7.08 B(-3.8%)
Dec 2015
$7.36 B(+19.6%)
$1.63 B(-8.6%)
$7.36 B(+1.3%)
Sep 2015
-
$1.78 B(-3.5%)
$7.27 B(+3.7%)
Jun 2015
-
$1.85 B(-11.9%)
$7.01 B(+3.6%)
Mar 2015
-
$2.10 B(+36.6%)
$6.76 B(+10.2%)
Dec 2014
$6.15 B(+9.7%)
$1.54 B(+0.8%)
$6.14 B(+3.3%)
Sep 2014
-
$1.52 B(-5.1%)
$5.95 B(+1.8%)
Jun 2014
-
$1.60 B(+8.8%)
$5.84 B(+1.8%)
Mar 2014
-
$1.47 B(+9.9%)
$5.74 B(+2.4%)
Dec 2013
$5.61 B(+10.2%)
$1.34 B(-5.5%)
$5.60 B(+0.5%)
Sep 2013
-
$1.42 B(-5.6%)
$5.58 B(+1.8%)
Jun 2013
-
$1.50 B(+12.4%)
$5.48 B(+3.4%)
Mar 2013
-
$1.34 B(+1.6%)
$5.30 B(+4.2%)
Dec 2012
$5.09 B(+21.8%)
$1.32 B(-0.3%)
$5.08 B(+3.1%)
Sep 2012
-
$1.32 B(-0.1%)
$4.93 B(+5.9%)
Jun 2012
-
$1.32 B(+17.4%)
$4.66 B(+7.0%)
Mar 2012
-
$1.13 B(-3.3%)
$4.35 B(+3.8%)
Dec 2011
$4.18 B(+24.3%)
$1.16 B(+11.5%)
$4.19 B(+9.8%)
Sep 2011
-
$1.04 B(+2.8%)
$3.82 B(+4.3%)
Jun 2011
-
$1.02 B(+5.1%)
$3.66 B(+4.4%)
Mar 2011
-
$966.88 M(+22.2%)
$3.51 B(+5.8%)
Dec 2010
$3.36 B(+17.7%)
$791.01 M(-10.9%)
$3.31 B(+0.2%)
Sep 2010
-
$888.25 M(+3.1%)
$3.31 B(+5.4%)
Jun 2010
-
$861.19 M(+11.4%)
$3.14 B(+3.7%)
Mar 2010
-
$773.15 M(-1.6%)
$3.03 B(+3.6%)
Dec 2009
$2.86 B(+16.9%)
$785.40 M(+9.1%)
$2.92 B(+6.7%)
Sep 2009
-
$719.57 M(-3.9%)
$2.74 B(+1.9%)
Jun 2009
-
$748.42 M(+12.1%)
$2.69 B(+6.0%)
Mar 2009
-
$667.67 M(+10.8%)
$2.54 B(+4.1%)
Dec 2008
$2.44 B(+48.4%)
$602.60 M(-9.9%)
$2.44 B(+18.4%)
Sep 2008
-
$668.90 M(+12.1%)
$2.06 B(+9.2%)
Jun 2008
-
$596.69 M(+4.9%)
$1.88 B(+4.9%)
Mar 2008
-
$568.66 M(+154.2%)
$1.80 B(+9.8%)
Dec 2007
$1.65 B(+7.3%)
$223.68 M(-54.8%)
$1.64 B(-7.9%)
Sep 2007
-
$494.88 M(-2.7%)
$1.78 B(+4.0%)
Jun 2007
-
$508.61 M(+24.6%)
$1.71 B(+3.9%)
Mar 2007
-
$408.19 M(+12.2%)
$1.64 B(+6.7%)
Dec 2006
$1.54 B(+13.9%)
$363.90 M(-14.8%)
$1.54 B(+4.0%)
Sep 2006
-
$426.95 M(-3.8%)
$1.48 B(+3.5%)
Jun 2006
-
$443.88 M(+45.7%)
$1.43 B(+3.4%)
Mar 2006
-
$304.64 M(-0.2%)
$1.38 B(+2.8%)
Dec 2005
$1.35 B(+14.7%)
$305.28 M(-19.1%)
$1.35 B(-2.2%)
Sep 2005
-
$377.50 M(-4.8%)
$1.38 B(+7.1%)
Jun 2005
-
$396.48 M(+48.8%)
$1.29 B(+7.6%)
Mar 2005
-
$266.44 M(-20.6%)
$1.19 B(+1.1%)
Dec 2004
$1.18 B
$335.65 M(+17.2%)
$1.18 B(-258.8%)
Sep 2004
-
$286.45 M(-6.4%)
-$743.79 M(+327.1%)
DateAnnualQuarterlyTTM
Jun 2004
-
$305.95 M(+20.8%)
-$174.15 M(-148.5%)
Mar 2004
-
$253.37 M(-115.9%)
$358.96 M(-57.5%)
Dec 2003
$973.92 M(+28.1%)
-$1.59 B(-285.7%)
$844.54 M(+12.6%)
Sep 2003
-
$856.09 M(+2.0%)
$750.05 M(+0.3%)
Jun 2003
-
$839.06 M(+13.5%)
$747.75 M(+33.1%)
Mar 2003
-
$738.95 M(-143.9%)
$561.66 M(+5.4%)
Dec 2002
$760.15 M(+13.0%)
-$1.68 B(-297.2%)
$532.93 M(-35.0%)
Sep 2002
-
$853.80 M(+30.8%)
$820.23 M(+7.5%)
Jun 2002
-
$652.97 M(-8.1%)
$763.23 M(-2.5%)
Mar 2002
-
$710.22 M(-150.8%)
$782.93 M(+6.6%)
Dec 2001
$672.69 M(+27.9%)
-$1.40 B(-275.3%)
$734.28 M(+64.1%)
Sep 2001
-
$796.80 M(+18.5%)
$447.56 M(-70.4%)
Jun 2001
-
$672.68 M(+1.7%)
$1.51 B(-8.4%)
Mar 2001
-
$661.56 M(-139.3%)
$1.65 B(-4.4%)
Dec 2000
$525.93 M(+25.6%)
-$1.68 B(-190.4%)
$1.73 B(+3.2%)
Sep 2000
-
$1.86 B(+129.8%)
$1.67 B(+164.8%)
Jun 2000
-
$810.58 M(+9.9%)
$631.91 M(+18.0%)
Mar 2000
-
$737.25 M(-142.4%)
$535.67 M(+7.6%)
Dec 1999
$418.81 M(+95.5%)
-$1.74 B(-311.5%)
$497.68 M(+24.2%)
Sep 1999
-
$821.66 M(+15.0%)
$400.56 M(+21.5%)
Jun 1999
-
$714.35 M(+2.2%)
$329.62 M(+16.3%)
Mar 1999
-
$699.25 M(-138.1%)
$283.42 M(+49.8%)
Dec 1998
$214.19 M(-39.5%)
-$1.83 B(-344.4%)
$189.17 M(-64.5%)
Sep 1998
-
$750.72 M(+12.4%)
$533.53 M(+30.1%)
Jun 1998
-
$668.15 M(+10.4%)
$410.22 M(+9.7%)
Mar 1998
-
$605.00 M(-140.6%)
$373.83 M(+8.7%)
Dec 1997
$354.00 M(+3.6%)
-$1.49 B(-337.5%)
$343.90 M(-1.1%)
Sep 1997
-
$627.41 M(-0.7%)
$347.59 M(-2.2%)
Jun 1997
-
$631.76 M(+9.9%)
$355.50 M(+10.7%)
Mar 1997
-
$575.07 M(-138.7%)
$321.20 M(-8.5%)
Dec 1996
$341.54 M(+2.1%)
-$1.49 B(-334.0%)
$351.00 M(+13.0%)
Sep 1996
-
$635.32 M(+6.3%)
$310.67 M(+22.2%)
Jun 1996
-
$597.46 M(-1.2%)
$254.25 M(-17.8%)
Mar 1996
-
$604.87 M(-139.6%)
$309.26 M(+10.6%)
Dec 1995
$334.50 M(+15.3%)
-$1.53 B(-363.8%)
$279.55 M(-39.6%)
Sep 1995
-
$578.90 M(-11.3%)
$462.93 M(+7.2%)
Jun 1995
-
$652.47 M(+13.4%)
$431.98 M(+41.5%)
Mar 1995
-
$575.16 M(-142.8%)
$305.32 M(+57.9%)
Dec 1994
$290.00 M(-3.4%)
-$1.34 B(-345.2%)
$193.31 M(-61.2%)
Sep 1994
-
$547.95 M(+4.2%)
$498.12 M(+20.1%)
Jun 1994
-
$525.81 M(+13.5%)
$414.84 M(+11.2%)
Mar 1994
-
$463.15 M(-144.6%)
$373.05 M(+13.9%)
Dec 1993
$300.23 M(+56.1%)
-$1.04 B(-323.6%)
$327.44 M(+42.2%)
Sep 1993
-
$464.66 M(-4.0%)
$230.21 M(+4.7%)
Jun 1993
-
$484.02 M(+15.9%)
$219.90 M(+17.9%)
Mar 1993
-
$417.53 M(-136.8%)
$186.47 M(-3.2%)
Dec 1992
$192.36 M(-12.6%)
-$1.14 B(-350.0%)
$192.69 M(-58.0%)
Sep 1992
-
$454.35 M(+0.8%)
$458.91 M(+27.5%)
Jun 1992
-
$450.60 M(+6.3%)
$359.94 M(+45.3%)
Mar 1992
-
$423.75 M(-148.7%)
$247.65 M(+17.7%)
Dec 1991
$220.07 M(+29.1%)
-$869.78 M(-344.7%)
$210.43 M(-4.3%)
Sep 1991
-
$355.38 M(+5.1%)
$219.95 M(+10.7%)
Jun 1991
-
$338.30 M(-12.5%)
$198.62 M(+11.5%)
Mar 1991
-
$386.54 M(-144.9%)
$178.09 M(+99.9%)
Dec 1990
$170.48 M(+18.5%)
-$860.27 M(-357.5%)
$89.08 M(-72.2%)
Sep 1990
-
$334.06 M(+5.1%)
$320.60 M(+45.5%)
Jun 1990
-
$317.76 M(+6.8%)
$220.29 M(+61.6%)
Mar 1990
-
$297.53 M(-147.3%)
$136.35 M(+19.6%)
Dec 1989
$143.85 M(+3.2%)
-$628.74 M(-369.0%)
$113.96 M(-61.5%)
Sep 1989
-
$233.75 M(-0.0%)
$295.66 M(+19.7%)
Jun 1989
-
$233.82 M(-15.0%)
$247.03 M(+9.3%)
Mar 1989
-
$275.14 M(-161.5%)
$226.03 M(+66.2%)
Dec 1988
$139.39 M(+47.1%)
-$447.04 M(-341.5%)
$136.02 M(+8.2%)
Sep 1988
-
$185.12 M(-13.0%)
$125.67 M(+3.7%)
Jun 1988
-
$212.81 M(+15.0%)
$121.19 M(+51.2%)
Mar 1988
-
$185.13 M(-140.5%)
$80.13 M(+12.1%)
Dec 1987
$94.76 M(+14.3%)
-$457.39 M(-353.2%)
$71.49 M(-64.6%)
Sep 1987
-
$180.64 M(+5.2%)
$202.13 M(+34.0%)
Jun 1987
-
$171.75 M(-2.7%)
$150.89 M(+33.6%)
Mar 1987
-
$176.49 M(-154.0%)
$112.91 M(+105.3%)
Dec 1986
$82.91 M(+18.9%)
-$326.75 M(-352.5%)
$55.00 M(-56.7%)
Sep 1986
-
$129.40 M(-3.3%)
$126.97 M(+35.8%)
Jun 1986
-
$133.77 M(+12.8%)
$93.51 M(+70.1%)
Mar 1986
-
$118.58 M(-146.5%)
$54.98 M(+90.2%)
Dec 1985
$69.75 M(+26.2%)
-$254.79 M(-365.6%)
$28.90 M(-65.6%)
Sep 1985
-
$95.94 M(+0.7%)
$83.91 M(+5.5%)
Jun 1985
-
$95.24 M(+3.0%)
$79.51 M(+5.4%)
Mar 1985
-
$92.51 M(-146.3%)
$75.44 M(+0.5%)
Dec 1984
$55.29 M
-$199.77 M(-318.2%)
$75.07 M(-72.7%)
Sep 1984
-
$91.54 M(+0.4%)
$274.84 M(+49.9%)
Jun 1984
-
$91.16 M(-1.1%)
$183.30 M(+98.9%)
Mar 1984
-
$92.14 M
$92.14 M

FAQ

  • What is Novo Nordisk A/S annual operating income?
  • What is the all time high annual operating profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual operating profit year-on-year change?
  • What is Novo Nordisk A/S quarterly operating income?
  • What is the all time high quarterly operating profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly operating profit year-on-year change?
  • What is Novo Nordisk A/S TTM operating income?
  • What is the all time high TTM operating profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM operating profit year-on-year change?

What is Novo Nordisk A/S annual operating income?

The current annual operating profit of NVO is $18.62 B

What is the all time high annual operating profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual operating income is $18.62 B

What is Novo Nordisk A/S annual operating profit year-on-year change?

Over the past year, NVO annual operating income has changed by +$3.73 B (+25.03%)

What is Novo Nordisk A/S quarterly operating income?

The current quarterly operating profit of NVO is $5.25 B

What is the all time high quarterly operating profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly operating income is $5.25 B

What is Novo Nordisk A/S quarterly operating profit year-on-year change?

Over the past year, NVO quarterly operating income has changed by +$1.51 B (+40.23%)

What is Novo Nordisk A/S TTM operating income?

The current TTM operating profit of NVO is $18.62 B

What is the all time high TTM operating profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM operating income is $18.62 B

What is Novo Nordisk A/S TTM operating profit year-on-year change?

Over the past year, NVO TTM operating income has changed by +$2.44 B (+15.09%)